Trials / Unknown
UnknownNCT05736575
Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (estimated)
- Sponsor
- Universidad Autonoma de Madrid · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
A case-control study will be conducted to analyze the differences in BDNF levels between patients with chronic pain and asymptomatic people.
Detailed description
Brain-derived neurotrophic factor (BDNF) is considered a biomarker of brain plasticity. Since different alterations in brain plasticity have been found in chronic pain patients, the investigators want to study whether there are differences at the molecular level in this population compared to an asymptomatic population in order to be able to accurately measure the impact of different physiotherapy interventions in an objective way.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | BDNF analysis (Elisa KIT) | Analysis of peripheral BDNF will be performed |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-02-28
- Completion
- 2024-12-30
- First posted
- 2023-02-21
- Last updated
- 2023-11-30
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05736575. Inclusion in this directory is not an endorsement.